Abstract
Colistin heteroresistance has been reported among Acinetobacter isolates; however, its association with prior colistin therapy has not been not described. A population analysis profile identified resistant Acinetobacter subpopulations from colistin-susceptible clinical isolates. The proportion of cells exhibiting heteroresistance was significantly higher among isolates recovered from patients treated with colistin.
Original language | English |
---|---|
Pages (from-to) | 351-352 |
Number of pages | 2 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 52 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2008 |
Externally published | Yes |